Statera Biopharma Inc Fka Cytocom Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Statera Biopharma Inc Fka Cytocom Inc's ROI in the third quarter of 2022?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Statera Biopharma Inc Fka Cytocom Inc 's return on investment (ROI) in its third quarter of 2022

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Investment Change TTM	-	-85.23 %	-47.21 %	27.86 %	223.08 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-10	-7	-2	10	88
Return On Investment (TTM)	-	-	-	-35.89 %	-18.71 %
STAB's Overall Ranking	# 5228	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-	-63.55 %	-39.05 %	-25.57 %	-10.69 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-26	-36	-39	-36	-25

STAB Company Profile >> Back to STAB Roi Comparisons >> See Annual STAB Return On Investment

Return On Investment STAB's Ranking
Within:	No.
Industry	# 526
Sector	# 1082
Overall	# 5228

Return On Investment Statistics
High	Average	Low
0.25 %	-282.24 %	-7731.39 %
(Dec. 30, 2014)		(Sep 30 2022)

Financial Statements
Statera Biopharma Inc Fka Cytocom Inc's III. Quarter Investments	$ -10 Millions	STAB's Balance sheet
Statera Biopharma Inc Fka Cytocom Inc's III. Quarter Income	$ -3 Millions	Quarterly STAB's Income Statement
STAB's Income by Division		See STAB's Income by Division

STAB Annual Return On Investment	(Dec 31 2021) 2021	(Dec 31 2020) 2020	(Dec 31 2019) 2019	(Dec 31 2018) 2018	(Dec 31 2017) 2017
Total Investments in Millions	10	7	6	9	13
Y / Y Investment Growth	42.92 %	25.75 %	-36.05 %	-31.18 %	-30.52 %
Net Income in Millions	-102	-2	-3	-4	-10
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-1020.22 %	-34.89 %	-56.92 %	-42.67 %	-77.96 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
STAB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for STAB's Competitors
Subscribers only: Roi for Statera Biopharma Inc Fka Cytocom Inc's Suppliers
Subscribers only: Return On Investment for STAB's Customers

Other Ratios
STAB's Roa	STAB's Inventory Turnover Ratio	STAB's Growth Rates	STAB's Dividend Statistics
	STAB's Profitability Ratios	STAB's Asset Turnover Ratio	STAB's Dividend Growth
STAB's Roe	STAB's Valuation Ratios	STAB's Financial Strength Ratios	STAB's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector

ROI

Date modified: 2026-06-22T14:32:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.